These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
625 related items for PubMed ID: 17537869
1. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Hoffmann M, DeMaio W, Jordan RA, Talaat R, Harper D, Speth J, Scatina J. Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869 [Abstract] [Full Text] [Related]
4. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S, Miura M, Toriumi C, Satoh Y, Ooie T. Drug Metab Dispos; 2007 Sep 01; 35(9):1624-33. PubMed ID: 17567733 [Abstract] [Full Text] [Related]
5. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects. Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sams JP, Johnson MG, Sanders PE, Hauer MJ, Fagerness PE, Stryd RP, Peng GW, Shobe EM. Drug Metab Dispos; 2001 Aug 01; 29(8):1136-45. PubMed ID: 11454733 [Abstract] [Full Text] [Related]
6. Disposition and biotransformation of the antiretroviral drug nevirapine in humans. Riska P, Lamson M, MacGregor T, Sabo J, Hattox S, Pav J, Keirns J. Drug Metab Dispos; 1999 Aug 01; 27(8):895-901. PubMed ID: 10421616 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S. Antimicrob Agents Chemother; 2005 Jan 01; 49(1):220-9. PubMed ID: 15616299 [Abstract] [Full Text] [Related]
8. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C, Kamel A, Gummerus J, Wilner K. Drug Metab Dispos; 1997 Jul 01; 25(7):863-72. PubMed ID: 9224781 [Abstract] [Full Text] [Related]
9. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline. Conte JE, Golden JA, Kelly MG, Zurlinden E. Int J Antimicrob Agents; 2005 Jun 01; 25(6):523-9. PubMed ID: 15885987 [Abstract] [Full Text] [Related]
10. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C, Soliman V. Drug Metab Dispos; 1997 Nov 01; 25(11):1288-97. PubMed ID: 9351906 [Abstract] [Full Text] [Related]
11. Absence of an interaction between tigecycline and digoxin in healthy men. Zimmerman JJ, Harper DM, Matschke K, Speth JL, Raible DG, Fruncillo RJ. Pharmacotherapy; 2007 Jun 01; 27(6):835-44. PubMed ID: 17542766 [Abstract] [Full Text] [Related]
12. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy. Colizza K, Awad M, Kamel A. Drug Metab Dispos; 2007 Jun 01; 35(6):884-97. PubMed ID: 17360832 [Abstract] [Full Text] [Related]
13. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H, Betsui H, Ohno Y. Toxicol Sci; 2003 May 01; 73(1):17-25. PubMed ID: 12700409 [Abstract] [Full Text] [Related]
14. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG. Drug Metab Dispos; 2000 May 01; 28(5):514-21. PubMed ID: 10772629 [Abstract] [Full Text] [Related]
15. Metabolism and excretion of ropivacaine in humans. Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M. Drug Metab Dispos; 1996 Sep 01; 24(9):962-8. PubMed ID: 8886605 [Abstract] [Full Text] [Related]
16. Disposition of [1'-(14)C]stavudine after oral administration to humans. Zhou L, Kaul S, Liu-Kreyche P, Tran SB, Espina RR, Warrack BM, Roongta VA, Iyer RA. Drug Metab Dispos; 2010 Apr 01; 38(4):655-66. PubMed ID: 20053818 [Abstract] [Full Text] [Related]
17. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. J Antimicrob Chemother; 2006 Dec 01; 58(6):1221-9. PubMed ID: 17012300 [Abstract] [Full Text] [Related]
18. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C, Schwarz T, Kubitza D, Mueck W, Lang D. Drug Metab Dispos; 2009 May 01; 37(5):1056-64. PubMed ID: 19196845 [Abstract] [Full Text] [Related]
19. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers. Polsky-Fisher SL, Vickers S, Cui D, Subramanian R, Arison BH, Agrawal NG, Goel TV, Vessey LK, Murphy MG, Lasseter KC, Simpson RC, Vega JM, Rodrigues AD. Drug Metab Dispos; 2006 Jun 01; 34(6):1004-11. PubMed ID: 16510541 [Abstract] [Full Text] [Related]
20. Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers. Stoltz R, Parisi S, Shah A, Macciocchi A. Biopharm Drug Dispos; 2004 Nov 01; 25(8):329-37. PubMed ID: 15378559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]